enhertu-powd-for-conc-for-soln-for-infusion-100-mg

Enhertu powd for conc for soln for infusion 100 mg (100 mg)

Manufacturer: Daiichi Sankyo

Distributor: Zuellig

Marketer: Daiichi Sankyo / AstraZeneca

Contents: trastuzumab deruxtecan

MIMS Class: Targeted Cancer Therapy

Form: Vial

Shape: Undefined

Exclusive offer for doctors

Register for a MIMS account and receive free medical publications worth $768 a year.

Already a member? Sign in